Compare Tripar Multivision Plus Tbk. (RAAM) vs Tempo Scan Pacific Tbk. (TSPC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Tripar Multivision Plus Tbk. vs Tempo Scan Pacific Tbk. — how do they compare? Tripar Multivision Plus Tbk. trades at Rp220 (market cap 1.38T, 6.69M 24h volume), while Tempo Scan Pacific Tbk. trades at Rp2,610 (market cap 11.64T, 278.4K 24h volume). The key difference: Tempo Scan Pacific Tbk. is far larger — about 8.4× Tripar Multivision Plus Tbk.'s market cap, and Tripar Multivision Plus Tbk. is more actively traded (6.69M versus 278.4K). Which is the better fit depends on your goals.
| RAAM | TSPC | |
|---|---|---|
Market Cap | 1.38T | 11.64T |
Volume | 6.69M | 278.4K |
Lot | 66.87K | 2.78K |
Turnover | 1.5B | 723.93M |
Average Price | 223.86 | 2,600.31 |
Value | 1.5B | 723.93M |
Indicative Equilibrium Price | 220 | 2,610 |
Indicative Equilibrium Volume | 781 | 74 |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Tripar Multivision Plus Tbk.
PT Tripar Multivision Plus Tbk (“the Company”) was establishedbased on Deed of Establishment of Limited Liability Company No. 17 dated 6 December 1990 drawn up before Adlan Yulizar, S.H., notary in Jakarta.
Read more on RAAM →About Tempo Scan Pacific Tbk.
PT. Tempo Scan Pacific Tbk (the Company) was established in the Republic of Indonesia dated 20 May 1970, under its original name PT Scanchemie within the framework of the Domestic Capital Investment Law No. 6 year 1968, as amended by Law No. 12 year 1970, based on Notarial Deed No. 37 of Ridwan Suselo, S.H. The company is famous for such pharmaceutical products as Bodrex, Hemaviton and Neo-Rheumacyl.
Read more on TSPC →
